Article info
PDFCorrespondence
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
- Correspondence to Dr Edoardo Conticini, Rheumatology Unit, University of Siena, Siena 53100, Italy; conticini.edoardo{at}gmail.com
Citation
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
Publication history
- Received April 20, 2020
- Revised April 22, 2020
- Accepted April 23, 2020
- First published May 15, 2020.
Online issue publication
January 12, 2021
Article Versions
- Previous version (15 May 2020).
- Previous version (23 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage